"Two new halocuprates complexes [CuII(1,4,8,11-tetraazacyclotetradecane)][CuI Cl3] and [H4(1,4,8,11-tetrazacyclotetradecane)][CuI 2Cl6]: synthesis, characterizations and biological studies" . "Medicinal Chemistry Research" . "11"^^ . "Two new halocuprates complexes [CuII(1,4,8,11-tetraazacyclotetradecane)][CuI Cl3] and [H4(1,4,8,11-tetrazacyclotetradecane)][CuI 2Cl6]: synthesis, characterizations and biological studies" . . "1054-2523" . "10.1007/s00044-011-9968-7" . . . "Choudhary, M. I." . "Two new halocuprates complexes [CuII(1,4,8,11-tetraazacyclotetradecane)][CuI Cl3] and [H4(1,4,8,11-tetrazacyclotetradecane)][CuI 2Cl6]: synthesis, characterizations and biological studies"@en . "Bezgour, A." . "Du\u0161ek, Michal" . "Khan, A." . . . "Siddiq, S." . "12"^^ . . . . . "000310030200037" . "RIV/68378271:_____/12:00388275!RIV13-AV0-68378271" . "US - Spojen\u00E9 st\u00E1ty americk\u00E9" . "Lachkar, M." . "Two new halocuprates complexes [CuII(1,4,8,11-tetraazacyclotetradecane)][CuI Cl3] and [H4(1,4,8,11-tetrazacyclotetradecane)][CuI 2Cl6]: synthesis, characterizations and biological studies"@en . "mixed valence; copper(I/II) complexes; halocuprates; tetraazacyclotetradecane; x-ray structures; beta-glucuronidase; enzyme inhibition"@en . "RIV/68378271:_____/12:00388275" . "El Bali, B." . . "12" . "Halime, I." . . . . "2"^^ . "Fejfarov\u00E1, Karla" . . "Z(AV0Z10100521)" . "Noreen, S." . . "Synthesis, crystal structures and biological activities for the new chlorobridged mixed valence CuI/CuII coordination polymer [CuIIcyclam][CuICl3] 1 and [H4cyclam][Cu2 I Cl6] 2 are reported. Compound 1 crystallizes in the orthorhombic system, space group Pccn. Its crystal structure consists of one-dimensional polymer CuIIcyclam\u2013Cl\u2013CuI\u2013Cl\u2013CuIIcyclam. Compound 2 is monoclinic (P21/n)with the tetraprotonated cyclam H4cyclam(4+) in (3,4,3,4)-B conformation. Compound 1 was tested to understand its influence on enzyme activity, immunomodulation as well as its toxicity and antiglycation potential. Its effect was significant as immunomodulatory and inhibitory activity against b-glucuronidase enzyme." . "Marasini, B. P." . "21" . . . "Rasheed, S." . "[B434CA6B60AC]" . "175466" . . "Synthesis, crystal structures and biological activities for the new chlorobridged mixed valence CuI/CuII coordination polymer [CuIIcyclam][CuICl3] 1 and [H4cyclam][Cu2 I Cl6] 2 are reported. Compound 1 crystallizes in the orthorhombic system, space group Pccn. Its crystal structure consists of one-dimensional polymer CuIIcyclam\u2013Cl\u2013CuI\u2013Cl\u2013CuIIcyclam. Compound 2 is monoclinic (P21/n)with the tetraprotonated cyclam H4cyclam(4+) in (3,4,3,4)-B conformation. Compound 1 was tested to understand its influence on enzyme activity, immunomodulation as well as its toxicity and antiglycation potential. Its effect was significant as immunomodulatory and inhibitory activity against b-glucuronidase enzyme."@en . . . .